News
-
-
-
COMMUNIQUÉ DE PRESSE
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Supira Medical announces FDA approval for SUPPORT II Pivotal Trial, advances in Cardiogenic Shock, and appointment of D. Keith Grossman to Board of Directors